DK1235573T3 - Kombination af riluzol og gabapentin og anvendelse deraf som medikament ved behandling af motorneuronsygdomme - Google Patents

Kombination af riluzol og gabapentin og anvendelse deraf som medikament ved behandling af motorneuronsygdomme

Info

Publication number
DK1235573T3
DK1235573T3 DK00985315T DK00985315T DK1235573T3 DK 1235573 T3 DK1235573 T3 DK 1235573T3 DK 00985315 T DK00985315 T DK 00985315T DK 00985315 T DK00985315 T DK 00985315T DK 1235573 T3 DK1235573 T3 DK 1235573T3
Authority
DK
Denmark
Prior art keywords
riluzole
gabapentin
combination
motor neuron
drug
Prior art date
Application number
DK00985315T
Other languages
English (en)
Inventor
Andrees Bohme
Christopher Henderson
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1235573T3 publication Critical patent/DK1235573T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DK00985315T 1999-11-24 2000-11-24 Kombination af riluzol og gabapentin og anvendelse deraf som medikament ved behandling af motorneuronsygdomme DK1235573T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9914765A FR2801217B1 (fr) 1999-11-24 1999-11-24 Association de riluzole et de gabapentine et son utilisation comme medicament
PCT/FR2000/003272 WO2001037832A2 (fr) 1999-11-24 2000-11-24 Association de riluzole et de gabapentine et son utilisation comme medicament

Publications (1)

Publication Number Publication Date
DK1235573T3 true DK1235573T3 (da) 2003-11-24

Family

ID=9552471

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00985315T DK1235573T3 (da) 1999-11-24 2000-11-24 Kombination af riluzol og gabapentin og anvendelse deraf som medikament ved behandling af motorneuronsygdomme

Country Status (10)

Country Link
EP (1) EP1235573B1 (da)
JP (1) JP4928697B2 (da)
AT (1) ATE245421T1 (da)
AU (1) AU2177401A (da)
DE (1) DE60004093T2 (da)
DK (1) DK1235573T3 (da)
ES (1) ES2198369T3 (da)
FR (1) FR2801217B1 (da)
PT (1) PT1235573E (da)
WO (1) WO2001037832A2 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1492519B1 (en) * 2003-03-21 2006-11-15 Dynogen Pharmaceuticals, Inc. Methods for treating lower urinary tract disorders using antimuscarinics and alpha-2-delta subunit calcium channel modulators
WO2004084881A1 (en) * 2003-03-21 2004-10-07 Dynogen Pharmaceuticals, Inc. METHODS FOR TREATING FUNCTIONAL BOWEL DISORDERS USING α2δ SUBUNIT CALCIUM CHANNEL MODULATORS WITH SMOOTH MUSCLE MODULATORS
WO2004084880A1 (en) * 2003-03-21 2004-10-07 Dynogen Pharmaceuticals, Inc. METHODS FOR TREATING PAIN USING SMOOTH MUSCLE MODULATORS AND α2δ SUBUNIT CALCIUM CHANNEL MODULATORS
CN104684558A (zh) 2012-07-31 2015-06-03 耶达研究及发展有限公司 诊断和治疗运动神经元疾病的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084479A (en) * 1990-01-02 1992-01-28 Warner-Lambert Company Novel methods for treating neurodegenerative diseases
FR2688138B1 (fr) * 1992-03-06 1995-05-05 Rhone Poulenc Rorer Sa Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique.
FR2702148B1 (fr) * 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
WO1999008670A1 (en) * 1997-08-20 1999-02-25 Guglietta, Antonio Gaba analogs to prevent and treat gastrointestinal damage

Also Published As

Publication number Publication date
DE60004093D1 (de) 2003-08-28
JP4928697B2 (ja) 2012-05-09
DE60004093T2 (de) 2004-06-03
FR2801217A1 (fr) 2001-05-25
WO2001037832A3 (fr) 2002-03-21
FR2801217B1 (fr) 2002-12-06
WO2001037832A2 (fr) 2001-05-31
ES2198369T3 (es) 2004-02-01
JP2003514858A (ja) 2003-04-22
ATE245421T1 (de) 2003-08-15
AU2177401A (en) 2001-06-04
EP1235573B1 (fr) 2003-07-23
EP1235573A2 (fr) 2002-09-04
PT1235573E (pt) 2003-11-28

Similar Documents

Publication Publication Date Title
BR0207760A (pt) Composição farmacêutica, uso da mesma, métodos para o tratamento de dor e de inflamação, e, processo para a preparação de uma composição
CY1106733T1 (el) Αγωγη νευρολογικης δυσλειτουργιας περιλαμβανουσα σουλφαμικες φρουκτοπυρανοζες και ερυθροποιητινη
GB0108592D0 (en) Therapeutic agents
AR021535A1 (es) Formas de dosificacion de liberacion controlada que comprenden zolpidem o sales del mismo
EP2087892A3 (en) (S,S) reboxetine for treating age associated learning and mental disorders
EE200300212A (et) Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks
ATE551996T1 (de) Behandlung oder prävention von diabetes mit cannabidiol
EA200100572A1 (ru) Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии
ATE472325T1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
ATE457166T1 (de) Orale zusammensetzungen zur behandlung von diabetes
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
BRPI0407662A (pt) derivados do ácido 1-fenilalcanocarboxìlico para o tratamento de doenças neurodegenerativas
NO307687B1 (no) Anvendelse av riluzol ved fremstilling av medikamenter for behandling av neuro-AIDS
CY1106155T1 (el) Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
BRPI0408491A (pt) tratamento da doença de alzheimer
PT1150704E (pt) Melagatran para o tratamento da inflamacao
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
DK1235573T3 (da) Kombination af riluzol og gabapentin og anvendelse deraf som medikament ved behandling af motorneuronsygdomme
YU39598A (sh) Upotreba duloksetina i njegova farmaceutska smeša
AU2001267864A1 (en) Remedial agent for optic nerve disease and the like
NO20012777L (no) Anvendelse av riluzol ved behandling av akustiske traumer
NO20042586L (no) Behandlingsfremgangsmate
BR0211836A (pt) Inibidor de anidrase carbÈnica
NO20044519L (no) Hyperforinderivater, anvendelse derav samt formuleringer som inneholder dem